犬の関節炎治療の世界市場:産業分析および機会分析

◆英語タイトル:Canine Arthritis Treatment Market - Global Industry Analysis and Opportunity Assessment, 2019-2029
◆商品コード:FMI20JA108
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2019年10月21日
◆ページ数:183
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Future Market Insights社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査は犬の関節炎治療について、エグゼクティブサマリー、市場概要、市場背景、市場状況、治療種類別(非ステロイド系抗炎症薬(NSAID)、オピオイド、幹細胞療法)分析、投与経路別(経口、注射)分析、流通経路別(獣医病院とクリニック、小売薬局、ドラッグストア、Eコマース)分析、地域別分析、競合分析、調査手法に区分して掲載しています。
・エグゼクティブサマリー
・市場概要
・市場背景
・市場状況
・犬の関節炎治療の世界市場:治療種類別(非ステロイド系抗炎症薬(NSAID)、オピオイド、幹細胞療法)
・犬の関節炎治療の世界市場:投与経路別(経口、注射)
・犬の関節炎治療の世界市場:流通経路別(獣医病院とクリニック、小売薬局、ドラッグストア、Eコマース)
・犬の関節炎治療の世界市場:地域別
・競合分析
・調査手法
【レポートの概要】

A recent market study published by Future Market Insights (FMI) on the canine arthritis treatment including global industry analysis 2014-2018 & opportunity assessment 2019-2029, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the canine arthritis treatment, the growth prospects of the market are obtained with maximum precision.

Chapter 01 – Executive Summary

The report initiates with the executive summary of the canine arthritis treatment, which includes a summary of key findings and statistics of the market. It also includes market size and revenue distribution of market segment of the canine arthritis treatment.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the canine arthritis treatment in this chapter, which will help them understand the basic information about the canine arthritis treatment.

Chapter 03 – Market Background

This chapter explains the key macroeconomic factors, drivers, restraints, trends and opportunity analysis that are expected to influence the growth of the canine arthritis treatment over the forecast period. Moreover, in-depth information about the market dynamics and their impact analysis on the market have been provided in the successive section.

Chapter 04 – Market Context

This section includes premium insights such as regulatory scenario, disease epidemiology, industry view point and market evolution. This section helps readers understand the key factors associated with the canine arthritis treatment market.

Chapter 05 – Global Canine Arthritis Treatment Value Analysis 2014-2018 & Opportunity Assessment 2019-2029

This section explains the global market value analysis and forecast for the Canine Arthritis treatment between the forecast periods of 2019-2029. This chapter includes a detailed analysis of the historical canine arthritis treatment market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

Chapter 06 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Treatment

Based on treatment type, the canine arthritis treatment market is segmented into Non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell therapy. In this chapter, readers can find information about the key trends and developments in the canine arthritis treatment and market attractiveness analysis based on treatment.

Chapter 07 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Route of Administration

This chapter provides details about the canine arthritis treatment based on mode of administration, and has been classified into oral and injectable. In this chapter, readers can understand the market attractiveness analysis based on route of administration.

Chapter 08 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Distribution Channel

This chapter provides details about the canine arthritis treatment market based on distribution channel, and has been classified into veterinary hospitals and clinics, retail pharmacies, drug stores, and E-Commerce. In this chapter, readers can understand the market attractiveness analysis based on distribution channel.

Chapter 09 – Global Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Region

This chapter explains how the canine arthritis treatment market will grow across various geographic regions such as North America, Latin America, Europe, Asia-Pacific excluding Japan, Japan, and Middle East & Africa (MEA).

Chapter 10 – North America Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter includes a detailed analysis of the growth of the North America canine arthritis treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the pricing analysis, regional trends, and market growth based on the application and countries in North America.

Chapter 11 – Latin America Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides the growth scenario of the canine arthritis treatment market in Latin American countries such as Brazil, Mexico, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 12 – Europe Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

Important growth prospects of the canine arthritis treatment market based on its Distribution Channels in several countries such as Germany, the U.K., France, Spain, Italy, Russia, and the Rest of Europe are included in this chapter.

Chapter 13 – Asia Pacific Excluding Japan Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter highlights the growth of the canine arthritis treatment in Asia pacific excluding Japan by focusing on China, India, Australia & New Zealand, ASEAN and rest of APEJ. This section also help readers understand the key factors that are responsible for the growth of the canine arthritis treatment market in the APEJ region.

Chapter 14 – Japan Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter highlights the growth of the canine arthritis treatment in Japan. This section also help readers understand the key factors that are responsible for the growth of the canine arthritis treatment market in Japan.

Chapter 15 – MEA Canine Arthritis Treatment Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides information about how the canine arthritis treatment market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period of 2019-2029.

Chapter 16 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the canine arthritis treatment market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Elanco, Zoetis, Bayer, VetStem Biopharma and among others.

Chapter 17 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the canine arthritis treatment report.

Chapter 18 – Research Methodology

This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about The Canine Arthritis Treatment.

【レポートの目次】

1. Executive Summary

1.1. Market Outlook

1.2. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Macro-Economic Factors

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity Analysis

3.1.4. Trends

4. Market Context

4.1. Global Healthcare Market Outlook

4.2. Global Canine Arthritis Treatment Scenario

4.3. Pet Ownership in European Union (EU)

4.4. Share of Household Owing at least one Dog in European Union (EU)

4.5. Spending on Health of Pets

4.6. Vet care Spending on Dogs

4.7. Key Regulations and Guidelines

5. Global Canine Arthritis Treatment Market (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029

5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

5.2.3. Market Value Comparison

6. Global Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Treatment Type

6.1. Introduction / Key Findings

6.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2014-2018

6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment Type, 2019 – 2029

6.3.1. Non-steroidal anti-inflammatory Medications (NSAIDs)

6.3.2. Opioids

6.3.3. Stem Cell Therapy

6.3.3.1. Allogeneic Stem Cells

6.3.3.2. Autologous Stem Cells

6.4. Market Attractiveness Analysis By Treatment Type

7. Global Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Route of Administration

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Route of Administration, 2014-2018

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Route of Administration, 2019 – 2029

7.3.1. Oral

7.3.2. Injectable

7.4. Market Attractiveness Analysis By Route of Administration

8. Global Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029

8.3.1. Veterinary Hospital and Clinics

8.3.2. Retail Pharmacies

8.3.3. Drug Stores

8.3.4. E-Commerce

8.3.5. Market Attractiveness Analysis By Distribution Channel

9. Global Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Region

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018

9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

9.3.1. North America

9.3.2. Latin America

9.3.3. Europe

9.3.4. Asia-Pacific Excluding Japan

9.3.5. Japan

9.3.6. Middle East and Africa

9.4. Market Attractiveness Analysis By Region

10. North America Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

10.3.1. By Country

10.3.1.1. U.S.

10.3.1.2. Canada

10.3.2. By Treatment Type

10.3.3. By Route of Administration

10.3.4. By Distribution Channel

10.4. Market Attractiveness Analysis

10.4.1. By Country

10.4.2. By Treatment Type

10.4.3. By Route of Administration

10.4.4. By Distribution Channel

11. Latin America Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

11.3.1. By Country

11.3.1.1. Mexico

11.3.1.2. Brazil

11.3.1.3. Rest of Latin America

11.3.2. By Treatment Type

11.3.3. By Route of Administration

11.3.4. By Distribution Channel

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Treatment Type

11.4.3. By Route of Administration

11.4.4. By Distribution Channel

12. Europe Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

12.3.1. By Country

12.3.1.1. Germany

12.3.1.2. Italy

12.3.1.3. France

12.3.1.4. U.K.

12.3.1.5. Spain

12.3.1.6. Russia

12.3.1.7. Rest of Europe

12.3.2. By Treatment Type

12.3.3. By Route of Administration

12.3.4. By Distribution Channel

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Treatment Type

12.4.3. By Route of Administration

12.4.4. By Distribution Channel

13. APEJ Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

13.3.1. By Country

13.3.1.1. China

13.3.1.2. India

13.3.1.3. Australia & New Zealand

13.3.1.4. ASEAN

13.3.1.5. Rest of APEJ

13.3.2. By Treatment Type

13.3.3. By Route of Administration

13.3.4. By Distribution Channel

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Treatment Type

13.4.3. By Route of Administration

13.4.4. By Distribution Channel

14. Japan Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

14.3.1. By Treatment Type

14.3.2. By Route of Administration

14.3.3. By Distribution Channel

14.4. Market Attractiveness Analysis

14.4.1. By Treatment Type

14.4.2. By Route of Administration

14.4.3. By Distribution Channel

15. Middle East and Africa Canine Arthritis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

15.3.1. By Country

15.3.1.1. GCC Countries

15.3.1.2. South Africa

15.3.1.3. Rest of MEA

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Treatment Type

15.4.3. By Route of Administration

16. Competition Analysis

16.1. Competition Dashboard

16.2. Competition Deep Dive

16.2.1. Elanco (Eli Lily and Company)

16.2.1.1. Overview

16.2.1.2. Product Portfolio

16.2.1.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.1.4. Sales Footprint

16.2.1.5. Strategy Overview

16.2.1.5.1. Marketing Strategy

16.2.1.5.2. Product Strategy

16.2.1.5.3. Route of Administration Strategy

16.2.2. Ceva Santé Animale

16.2.2.1. Overview

16.2.2.2. Product Portfolio

16.2.2.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.2.4. Sales Footprint

16.2.2.5. Strategy Overview

16.2.2.5.1. Marketing Strategy

16.2.2.5.2. Product Strategy

16.2.2.5.3. Route of Administration Strategy

16.2.3. Vetoquinol S.A

16.2.3.1. Overview

16.2.3.2. Product Portfolio

16.2.3.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.3.4. Sales Footprint

16.2.3.5. Strategy Overview

16.2.3.5.1. Marketing Strategy

16.2.3.5.2. Product Strategy

16.2.3.5.3. Route of Administration Strategy

16.2.4. Norbrook Laboratories Limited

16.2.4.1. Overview

16.2.4.2. Product Portfolio

16.2.4.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.4.4. Sales Footprint

16.2.4.5. Strategy Overview

16.2.4.5.1. Marketing Strategy

16.2.4.5.2. Product Strategy

16.2.4.5.3. Route of Administration Strategy

16.2.5. Aratana Therapeutics IncMylan Pharmaceuticals Inc.

16.2.5.1. Overview

16.2.5.2. Product Portfolio

16.2.5.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.5.4. Sales Footprint

16.2.5.5. Strategy Overview

16.2.5.5.1. Marketing Strategy

16.2.5.5.2. Product Strategy

16.2.5.5.3. Route of Administration Strategy

16.2.6. Boehringer Ingelheim

16.2.6.1. Overview

16.2.6.2. Product Portfolio

16.2.6.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.6.4. Sales Footprint

16.2.6.5. Strategy Overview

16.2.6.5.1. Marketing Strategy

16.2.6.5.2. Product Strategy

16.2.6.5.3. Route of Administration Strategy

16.2.7. Zoetis Inc

16.2.7.1. Overview

16.2.7.2. Product Portfolio

16.2.7.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.7.4. Sales Footprint

16.2.7.5. Strategy Overview

16.2.7.5.1. Marketing Strategy

16.2.7.5.2. Product Strategy

16.2.7.5.3. Route of Administration Strategy

16.2.8. Bayer AG

16.2.8.1. Overview

16.2.8.2. Product Portfolio

16.2.8.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.8.4. Sales Footprint

16.2.8.5. Strategy Overview

16.2.8.5.1. Marketing Strategy

16.2.8.5.2. Product Strategy

16.2.8.5.3. Route of Administration Strategy

16.2.9. VetStem Biopharma

16.2.9.1. Overview

16.2.9.2. Product Portfolio

16.2.9.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.9.4. Sales Footprint

16.2.9.5. Strategy Overview

16.2.9.5.1. Marketing Strategy

16.2.9.5.2. Product Strategy

16.2.9.5.3. Route of Administration Strategy

16.2.10. Dechra Pharmaceuticals PLC

16.2.10.1. Overview

16.2.10.2. Product Portfolio

16.2.10.3. Profitability by Market Segments (Product/Route of Administration/Region)

16.2.10.4. Sales Footprint

16.2.10.5. Strategy Overview

16.2.10.5.1. Marketing Strategy

16.2.10.5.2. Product Strategy

16.2.10.5.3. Route of Administration Strategy

17. Assumptions and Acronyms Used

18. Research Methodology



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[犬の関節炎治療の世界市場:産業分析および機会分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆